Lymph Node Mapping in Patients With Endometrial Cancer

• Status: Completed
• Trial end date: 2017-03-31
• Target enrollment: 0
• Participant gender: Female

Summary

This clinical trial studies lymph node mapping in patients with endometrial cancer. Lymph node mapping may allow for limited removal of lymph nodes in as part of endometrial cancer staging and treatment.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ohio State University Comprehensive Cancer Center
• Treatments: Pharmaceutical Solutions

Criteria

Inclusion Criteria:

• The patient must be willing and able to provide informed consent

• The patient is willing and able to comply with the study protocol

• The patient has endometrial cancer and is scheduled for robotic hysterectomy and lymphadenectomy

• The patient agrees to follow-up examinations out to 5-years post-treatment

Exclusion Criteria:

• The patient is not a candidate for robotic assisted hysterectomy and lymphadenectomy

• The patient has known or suspected allergies to iodine, indocyanine green (ICG) or isosulfan blue (ISB)

• The patient has hepatic dysfunction confirmed by bilirubin > 2 x normal (based on reference values from the laboratory used by the patient)